

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 7.27874289 |
| 2 | central nervous system myelination (GO:0022010) | 5.71370823 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 5.71370823 |
| 4 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.21312642 |
| 5 | ensheathment of neurons (GO:0007272) | 5.18151993 |
| 6 | axon ensheathment (GO:0008366) | 5.18151993 |
| 7 | myelination (GO:0042552) | 5.06053879 |
| 8 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.63746610 |
| 9 | wound healing, spreading of epidermal cells (GO:0035313) | 4.51313305 |
| 10 | adhesion of symbiont to host cell (GO:0044650) | 4.37325467 |
| 11 | virion attachment to host cell (GO:0019062) | 4.37325467 |
| 12 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 4.22800553 |
| 13 | protein localization to endosome (GO:0036010) | 4.07281516 |
| 14 | peripheral nervous system axon ensheathment (GO:0032292) | 4.03028833 |
| 15 | myelination in peripheral nervous system (GO:0022011) | 4.03028833 |
| 16 | low-density lipoprotein particle clearance (GO:0034383) | 4.02364787 |
| 17 | morphogenesis of an endothelium (GO:0003159) | 3.94243593 |
| 18 | endothelial tube morphogenesis (GO:0061154) | 3.94243593 |
| 19 | sprouting angiogenesis (GO:0002040) | 3.91464240 |
| 20 | endodermal cell differentiation (GO:0035987) | 3.87921426 |
| 21 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.78419984 |
| 22 | myelin maintenance (GO:0043217) | 3.76234963 |
| 23 | astrocyte development (GO:0014002) | 3.75675692 |
| 24 | adhesion of symbiont to host (GO:0044406) | 3.74710630 |
| 25 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.74089226 |
| 26 | fatty acid elongation (GO:0030497) | 3.70333913 |
| 27 | cell-substrate junction assembly (GO:0007044) | 3.67659217 |
| 28 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.63069110 |
| 29 | Notch signaling involved in heart development (GO:0061314) | 3.61420319 |
| 30 | negative regulation of focal adhesion assembly (GO:0051895) | 3.58950975 |
| 31 | negative regulation of cell junction assembly (GO:1901889) | 3.58950975 |
| 32 | negative regulation of adherens junction organization (GO:1903392) | 3.58950975 |
| 33 | creatine metabolic process (GO:0006600) | 3.50806834 |
| 34 | negative regulation of endothelial cell migration (GO:0010596) | 3.50621731 |
| 35 | endothelial cell morphogenesis (GO:0001886) | 3.44837424 |
| 36 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.44091954 |
| 37 | basement membrane organization (GO:0071711) | 3.37930451 |
| 38 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.35749724 |
| 39 | cellular response to epinephrine stimulus (GO:0071872) | 3.35422995 |
| 40 | cell migration involved in heart development (GO:0060973) | 3.32587081 |
| 41 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.31747213 |
| 42 | endothelial cell differentiation (GO:0045446) | 3.29082432 |
| 43 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.28231633 |
| 44 | asymmetric protein localization (GO:0008105) | 3.26465859 |
| 45 | patterning of blood vessels (GO:0001569) | 3.25812377 |
| 46 | chondrocyte proliferation (GO:0035988) | 3.23497822 |
| 47 | L-serine transport (GO:0015825) | 3.19886291 |
| 48 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.19438541 |
| 49 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.19116915 |
| 50 | apical protein localization (GO:0045176) | 3.18928245 |
| 51 | positive regulation of odontogenesis (GO:0042482) | 3.18907214 |
| 52 | wound healing, spreading of cells (GO:0044319) | 3.18553606 |
| 53 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.17737516 |
| 54 | substrate-dependent cell migration (GO:0006929) | 3.17001279 |
| 55 | ovulation from ovarian follicle (GO:0001542) | 3.15651139 |
| 56 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.15415724 |
| 57 | regulation of endothelial cell differentiation (GO:0045601) | 3.15151540 |
| 58 | membrane raft organization (GO:0031579) | 3.14407296 |
| 59 | protein heterotrimerization (GO:0070208) | 3.13677284 |
| 60 | negative regulation of cartilage development (GO:0061037) | 3.09612623 |
| 61 | positive regulation of urine volume (GO:0035810) | 3.07696117 |
| 62 | adherens junction assembly (GO:0034333) | 3.07606901 |
| 63 | import into cell (GO:0098657) | 3.07117551 |
| 64 | enteric nervous system development (GO:0048484) | 3.06240446 |
| 65 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.04747552 |
| 66 | negative regulation of protein localization to cell surface (GO:2000009) | 3.00443691 |
| 67 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.99171003 |
| 68 | membrane assembly (GO:0071709) | 2.98944741 |
| 69 | blood vessel maturation (GO:0001955) | 2.98747904 |
| 70 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.97656738 |
| 71 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.96823978 |
| 72 | positive regulation of receptor recycling (GO:0001921) | 2.96220652 |
| 73 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.95388814 |
| 74 | positive regulation of glomerulus development (GO:0090193) | 2.95229611 |
| 75 | neuron remodeling (GO:0016322) | 2.94960066 |
| 76 | nephron epithelium development (GO:0072009) | 2.92801373 |
| 77 | endothelial cell proliferation (GO:0001935) | 2.92693391 |
| 78 | artery development (GO:0060840) | 2.89006014 |
| 79 | negative regulation of fatty acid transport (GO:2000192) | 2.89004325 |
| 80 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.87616700 |
| 81 | apoptotic cell clearance (GO:0043277) | 2.85197376 |
| 82 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.84943599 |
| 83 | cell-substrate adherens junction assembly (GO:0007045) | 2.84388865 |
| 84 | focal adhesion assembly (GO:0048041) | 2.84388865 |
| 85 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.83238121 |
| 86 | axon extension involved in axon guidance (GO:0048846) | 2.83238121 |
| 87 | oligodendrocyte differentiation (GO:0048709) | 2.83003009 |
| 88 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.82792625 |
| 89 | response to lipoprotein particle (GO:0055094) | 2.81228038 |
| 90 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.80458683 |
| 91 | atrioventricular valve morphogenesis (GO:0003181) | 2.79449485 |
| 92 | positive regulation of endothelial cell migration (GO:0010595) | 2.79443590 |
| 93 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.79395216 |
| 94 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.77757128 |
| 95 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.77140923 |
| 96 | triglyceride catabolic process (GO:0019433) | 2.76963533 |
| 97 | hemidesmosome assembly (GO:0031581) | 2.76721447 |
| 98 | regulation of endothelial cell migration (GO:0010594) | 2.76079074 |
| 99 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.75750177 |
| 100 | glomerular basement membrane development (GO:0032836) | 2.75521444 |
| 101 | barbed-end actin filament capping (GO:0051016) | 2.74725581 |
| 102 | endocardial cushion development (GO:0003197) | 2.74630837 |
| 103 | extracellular fibril organization (GO:0043206) | 2.74381206 |
| 104 | lymphangiogenesis (GO:0001946) | 2.72890814 |
| 105 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.71688988 |
| 106 | vasculogenesis (GO:0001570) | 2.71656240 |
| 107 | regulation of cardioblast differentiation (GO:0051890) | 2.71318063 |
| 108 | endothelial cell chemotaxis (GO:0035767) | 2.70917493 |
| 109 | response to epinephrine (GO:0071871) | 2.70651327 |
| 110 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.70131130 |
| 111 | cortical actin cytoskeleton organization (GO:0030866) | 2.69648191 |
| 112 | positive regulation of osteoblast proliferation (GO:0033690) | 2.68929371 |
| 113 | blood vessel endothelial cell migration (GO:0043534) | 2.68238086 |
| 114 | actin filament depolymerization (GO:0030042) | 2.67612364 |
| 115 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.66055697 |
| 116 | response to dietary excess (GO:0002021) | 2.65892154 |
| 117 | protein localization to cell surface (GO:0034394) | 2.65581951 |
| 118 | negative regulation of epithelial cell migration (GO:0010633) | 2.65538419 |
| 119 | white fat cell differentiation (GO:0050872) | 2.65211855 |
| 120 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.63970891 |
| 121 | thioester biosynthetic process (GO:0035384) | 2.63669313 |
| 122 | acyl-CoA biosynthetic process (GO:0071616) | 2.63669313 |
| 123 | Leydig cell differentiation (GO:0033327) | 2.62565121 |
| 124 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.62408869 |
| 125 | lymph vessel development (GO:0001945) | 2.62163348 |
| 126 | regulation of lipoprotein metabolic process (GO:0050746) | 2.60576577 |
| 127 | triglyceride biosynthetic process (GO:0019432) | 2.60516966 |
| 128 | * angiogenesis (GO:0001525) | 2.60000211 |
| 129 | blood vessel remodeling (GO:0001974) | 2.59799510 |
| 130 | * renal filtration (GO:0097205) | 2.57881398 |
| 131 | mesodermal cell differentiation (GO:0048333) | 2.57467814 |
| 132 | negative regulation of angiogenesis (GO:0016525) | 2.56884575 |
| 133 | cell adhesion mediated by integrin (GO:0033627) | 2.56743590 |
| 134 | endocrine hormone secretion (GO:0060986) | 2.55998640 |
| 135 | stress fiber assembly (GO:0043149) | 2.55767870 |
| 136 | regulation of glomerular filtration (GO:0003093) | 2.55663743 |
| 137 | heart trabecula formation (GO:0060347) | 2.55416700 |
| 138 | extracellular matrix disassembly (GO:0022617) | 2.55249863 |
| 139 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.54841978 |
| 140 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.54257436 |
| 141 | epithelial cell-cell adhesion (GO:0090136) | 2.53984341 |
| 142 | negative regulation of platelet activation (GO:0010544) | 2.53687720 |
| 143 | eye photoreceptor cell differentiation (GO:0001754) | 2.53528590 |
| 144 | photoreceptor cell differentiation (GO:0046530) | 2.53528590 |
| 145 | nerve growth factor signaling pathway (GO:0038180) | 2.53057041 |
| 146 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.52894190 |
| 147 | collagen metabolic process (GO:0032963) | 2.52678639 |
| 148 | * glomerular filtration (GO:0003094) | 2.52367153 |
| 149 | serine transport (GO:0032329) | 2.52362152 |
| 150 | embryonic heart tube development (GO:0035050) | 2.51199500 |
| 151 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.50710612 |
| 152 | semaphorin-plexin signaling pathway (GO:0071526) | 2.49739051 |
| 153 | neutral lipid biosynthetic process (GO:0046460) | 2.48924262 |
| 154 | acylglycerol biosynthetic process (GO:0046463) | 2.48924262 |
| 155 | cellular response to catecholamine stimulus (GO:0071870) | 2.47902654 |
| 156 | cellular response to monoamine stimulus (GO:0071868) | 2.47902654 |
| 157 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.45845564 |
| 158 | growth hormone receptor signaling pathway (GO:0060396) | 2.45377145 |
| 159 | response to hepatocyte growth factor (GO:0035728) | 2.44908701 |
| 160 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.44908701 |
| 161 | glycerolipid catabolic process (GO:0046503) | 2.43328896 |
| 162 | hypotonic response (GO:0006971) | 2.42291454 |
| 163 | polarized epithelial cell differentiation (GO:0030859) | 2.41806058 |
| 164 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.38956366 |
| 165 | cortical cytoskeleton organization (GO:0030865) | 2.38888839 |
| 166 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.38847739 |
| 167 | regulation of receptor binding (GO:1900120) | 2.38730381 |
| 168 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.38531703 |
| 169 | regulation of vasculogenesis (GO:2001212) | 2.38244606 |
| 170 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.37896856 |
| 171 | lipid particle organization (GO:0034389) | 2.37695701 |
| 172 | collagen fibril organization (GO:0030199) | 2.36694949 |
| 173 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.36588084 |
| 174 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.35447262 |
| 175 | neutral lipid catabolic process (GO:0046461) | 2.35380533 |
| 176 | acylglycerol catabolic process (GO:0046464) | 2.35380533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.39523108 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.04669778 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.68666275 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57990316 |
| 5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.46084275 |
| 6 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.40745310 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21253129 |
| 8 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.19955224 |
| 9 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.19354559 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17763075 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08305291 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.95042229 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92477268 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.92341264 |
| 15 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87528652 |
| 16 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87528652 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86060264 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82642809 |
| 19 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.79875094 |
| 20 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.77827154 |
| 21 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.72172628 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.69527858 |
| 23 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.68381380 |
| 24 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.68381380 |
| 25 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.68381380 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.68296113 |
| 27 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.64169812 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62022931 |
| 29 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.61111035 |
| 30 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.59885646 |
| 31 | CJUN_26792858_Chip-Seq_BT549_Human | 1.58918029 |
| 32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57945834 |
| 33 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.57485680 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.51386777 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50752440 |
| 36 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.50401071 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49137652 |
| 38 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48851161 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46728442 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44735264 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41867306 |
| 42 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41509139 |
| 43 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.41471990 |
| 44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41000240 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39511390 |
| 46 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.39453820 |
| 47 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.39453820 |
| 48 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39187370 |
| 49 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37707147 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36060276 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36019255 |
| 52 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36005713 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35024133 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34225839 |
| 55 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34134272 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.32562833 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31541975 |
| 58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30068460 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29864641 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29864641 |
| 61 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.27435965 |
| 62 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.27305659 |
| 63 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.26986474 |
| 64 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.26860279 |
| 65 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.26407992 |
| 66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25345512 |
| 67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25345512 |
| 68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24812545 |
| 69 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.24388679 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23693473 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23241155 |
| 72 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.22865270 |
| 73 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21424793 |
| 74 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21050453 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21023720 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20068687 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19402512 |
| 78 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.19030586 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17500447 |
| 80 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.16186672 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.16145711 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15366934 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14124687 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14110707 |
| 85 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.13968064 |
| 86 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13551408 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12556201 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12491395 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12181656 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10807915 |
| 91 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10153197 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10100785 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09677483 |
| 94 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09069978 |
| 95 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.07170709 |
| 96 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06925394 |
| 97 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05589207 |
| 98 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05530901 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04908355 |
| 100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04553783 |
| 101 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.02655583 |
| 102 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01258617 |
| 103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01156292 |
| 104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01154398 |
| 105 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01073613 |
| 106 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00790408 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00406598 |
| 108 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98189351 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96846047 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96649954 |
| 111 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96580584 |
| 112 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.96418432 |
| 113 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96409645 |
| 114 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95910973 |
| 115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94863964 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93723615 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93651023 |
| 118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92905742 |
| 119 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92842810 |
| 120 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92661770 |
| 121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92030446 |
| 122 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91848037 |
| 123 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91700888 |
| 124 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.91213933 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90342872 |
| 126 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89109942 |
| 127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88983941 |
| 128 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88760307 |
| 129 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87962172 |
| 130 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87759659 |
| 131 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.86332464 |
| 132 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86284905 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85805340 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85022264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004272_abnormal_basement_membrane | 5.15102109 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.85339899 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.31093067 |
| 4 | MP0000920_abnormal_myelination | 2.93957977 |
| 5 | MP0005623_abnormal_meninges_morphology | 2.90654726 |
| 6 | MP0005275_abnormal_skin_tensile | 2.75486079 |
| 7 | MP0010368_abnormal_lymphatic_system | 2.68730252 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 2.64087904 |
| 9 | MP0005670_abnormal_white_adipose | 2.61978907 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.59196438 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.51066288 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.42489991 |
| 13 | MP0000751_myopathy | 2.34399533 |
| 14 | MP0005666_abnormal_adipose_tissue | 2.34056452 |
| 15 | MP0005409_darkened_coat_color | 2.28082853 |
| 16 | MP0003690_abnormal_glial_cell | 2.21149031 |
| 17 | MP0001879_abnormal_lymphatic_vessel | 2.18339965 |
| 18 | MP0005375_adipose_tissue_phenotype | 2.14054185 |
| 19 | MP0004130_abnormal_muscle_cell | 2.04451330 |
| 20 | MP0006138_congestive_heart_failure | 2.03279374 |
| 21 | MP0000003_abnormal_adipose_tissue | 2.01931949 |
| 22 | MP0004036_abnormal_muscle_relaxation | 2.01705731 |
| 23 | MP0010030_abnormal_orbit_morphology | 1.95413782 |
| 24 | MP0005171_absent_coat_pigmentation | 1.91475475 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.90969133 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.88481856 |
| 27 | MP0001958_emphysema | 1.85429597 |
| 28 | MP0003279_aneurysm | 1.84522688 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.73825402 |
| 30 | MP0001661_extended_life_span | 1.73284698 |
| 31 | MP0003828_pulmonary_edema | 1.67755901 |
| 32 | MP0005330_cardiomyopathy | 1.64368050 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.60883748 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.58866855 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.55539020 |
| 36 | MP0003045_fibrosis | 1.54822758 |
| 37 | MP0003634_abnormal_glial_cell | 1.47077382 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.46148488 |
| 39 | MP0000462_abnormal_digestive_system | 1.43681123 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.40294544 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.39440746 |
| 42 | MP0001849_ear_inflammation | 1.37880705 |
| 43 | MP0005620_abnormal_muscle_contractility | 1.37591205 |
| 44 | MP0000747_muscle_weakness | 1.35092772 |
| 45 | MP0002933_joint_inflammation | 1.33215108 |
| 46 | MP0000383_abnormal_hair_follicle | 1.31355865 |
| 47 | MP0002972_abnormal_cardiac_muscle | 1.29526109 |
| 48 | MP0004270_analgesia | 1.27463152 |
| 49 | MP0001915_intracranial_hemorrhage | 1.27186852 |
| 50 | MP0003091_abnormal_cell_migration | 1.24671437 |
| 51 | MP0000537_abnormal_urethra_morphology | 1.24297334 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.23239328 |
| 53 | MP0000749_muscle_degeneration | 1.22695349 |
| 54 | MP0005023_abnormal_wound_healing | 1.20942115 |
| 55 | MP0004147_increased_porphyrin_level | 1.20226573 |
| 56 | MP0001727_abnormal_embryo_implantation | 1.17331850 |
| 57 | MP0010630_abnormal_cardiac_muscle | 1.16708485 |
| 58 | MP0002108_abnormal_muscle_morphology | 1.16444406 |
| 59 | MP0004215_abnormal_myocardial_fiber | 1.16202170 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.15959883 |
| 61 | MP0001544_abnormal_cardiovascular_syste | 1.15900050 |
| 62 | MP0005385_cardiovascular_system_phenoty | 1.15900050 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.12062337 |
| 64 | MP0003329_amyloid_beta_deposits | 1.11558550 |
| 65 | MP0000733_abnormal_muscle_development | 1.08910435 |
| 66 | MP0004233_abnormal_muscle_weight | 1.08615252 |
| 67 | MP0009384_cardiac_valve_regurgitation | 1.07663301 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 1.07645753 |
| 69 | MP0006054_spinal_hemorrhage | 1.05719868 |
| 70 | MP0000767_abnormal_smooth_muscle | 1.04454431 |
| 71 | MP0000534_abnormal_ureter_morphology | 1.03946411 |
| 72 | MP0001299_abnormal_eye_distance/ | 1.03336242 |
| 73 | MP0003959_abnormal_lean_body | 1.02822166 |
| 74 | MP0004885_abnormal_endolymph | 1.01287737 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.00304487 |
| 76 | MP0000759_abnormal_skeletal_muscle | 1.00259586 |
| 77 | MP0003868_abnormal_feces_composition | 0.99528552 |
| 78 | MP0003632_abnormal_nervous_system | 0.99440370 |
| 79 | MP0005388_respiratory_system_phenotype | 0.99440337 |
| 80 | MP0002133_abnormal_respiratory_system | 0.99440337 |
| 81 | MP0002896_abnormal_bone_mineralization | 0.95726271 |
| 82 | MP0001614_abnormal_blood_vessel | 0.94519269 |
| 83 | MP0004484_altered_response_of | 0.93488035 |
| 84 | MP0004085_abnormal_heartbeat | 0.92771558 |
| 85 | MP0003137_abnormal_impulse_conducting | 0.91059932 |
| 86 | MP0005595_abnormal_vascular_smooth | 0.89794706 |
| 87 | MP0004134_abnormal_chest_morphology | 0.89684938 |
| 88 | MP0002128_abnormal_blood_circulation | 0.89678721 |
| 89 | MP0002925_abnormal_cardiovascular_devel | 0.89309388 |
| 90 | MP0003385_abnormal_body_wall | 0.88331235 |
| 91 | MP0005197_abnormal_uvea_morphology | 0.84769148 |
| 92 | MP0002971_abnormal_brown_adipose | 0.84747483 |
| 93 | MP0000467_abnormal_esophagus_morphology | 0.83920962 |
| 94 | MP0005164_abnormal_response_to | 0.81799527 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.80983324 |
| 96 | MP0003941_abnormal_skin_development | 0.80343033 |
| 97 | MP0002970_abnormal_white_adipose | 0.78728321 |
| 98 | MP0000762_abnormal_tongue_morphology | 0.78168615 |
| 99 | MP0005369_muscle_phenotype | 0.75359146 |
| 100 | MP0009115_abnormal_fat_cell | 0.74593139 |
| 101 | MP0009053_abnormal_anal_canal | 0.74028287 |
| 102 | MP0002106_abnormal_muscle_physiology | 0.72632236 |
| 103 | MP0004858_abnormal_nervous_system | 0.71349908 |
| 104 | MP0001348_abnormal_lacrimal_gland | 0.70906459 |
| 105 | MP0003937_abnormal_limbs/digits/tail_de | 0.70296322 |
| 106 | MP0002127_abnormal_cardiovascular_syste | 0.68933644 |
| 107 | MP0003948_abnormal_gas_homeostasis | 0.67440581 |
| 108 | MP0005165_increased_susceptibility_to | 0.66609688 |
| 109 | MP0000249_abnormal_blood_vessel | 0.66579491 |
| 110 | MP0000778_abnormal_nervous_system | 0.66430379 |
| 111 | MP0003136_yellow_coat_color | 0.64938222 |
| 112 | MP0000343_altered_response_to | 0.64531782 |
| 113 | MP0002932_abnormal_joint_morphology | 0.64435103 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.63927769 |
| 115 | MP0005508_abnormal_skeleton_morphology | 0.63371982 |
| 116 | MP0000266_abnormal_heart_morphology | 0.63308114 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.62745138 |
| 118 | MP0002060_abnormal_skin_morphology | 0.62200110 |
| 119 | MP0001784_abnormal_fluid_regulation | 0.61842353 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.61360793 |
| 121 | MP0002796_impaired_skin_barrier | 0.61015273 |
| 122 | MP0002168_other_aberrant_phenotype | 0.60376315 |
| 123 | MP0003631_nervous_system_phenotype | 0.59879023 |
| 124 | MP0002269_muscular_atrophy | 0.59704334 |
| 125 | MP0003724_increased_susceptibility_to | 0.58293823 |
| 126 | MP0002697_abnormal_eye_size | 0.57742430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.42565706 |
| 2 | Muscle fiber splitting (HP:0003555) | 4.28548929 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 4.14887078 |
| 4 | Broad metatarsal (HP:0001783) | 4.00267486 |
| 5 | Sensory axonal neuropathy (HP:0003390) | 3.82615549 |
| 6 | Difficulty running (HP:0009046) | 3.76495658 |
| 7 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.69336295 |
| 8 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.69336295 |
| 9 | Cerebral aneurysm (HP:0004944) | 3.49945162 |
| 10 | Wrist flexion contracture (HP:0001239) | 3.45213641 |
| 11 | Insidious onset (HP:0003587) | 3.44528249 |
| 12 | Termporal pattern (HP:0011008) | 3.44528249 |
| 13 | Aortic dissection (HP:0002647) | 3.33223239 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.22937242 |
| 15 | Onion bulb formation (HP:0003383) | 3.21616017 |
| 16 | Ulnar claw (HP:0001178) | 3.12074859 |
| 17 | Polycythemia (HP:0001901) | 3.09452852 |
| 18 | Hypoplasia of the iris (HP:0007676) | 3.09360758 |
| 19 | Shallow orbits (HP:0000586) | 2.98492600 |
| 20 | Nonimmune hydrops fetalis (HP:0001790) | 2.94156923 |
| 21 | Esophageal varix (HP:0002040) | 2.94106298 |
| 22 | Increased variability in muscle fiber diameter (HP:0003557) | 2.93947228 |
| 23 | Acanthosis nigricans (HP:0000956) | 2.92942449 |
| 24 | Scapular winging (HP:0003691) | 2.89360665 |
| 25 | Ankle contracture (HP:0006466) | 2.86779751 |
| 26 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.86175622 |
| 27 | Atrophic scars (HP:0001075) | 2.84288502 |
| 28 | Protrusio acetabuli (HP:0003179) | 2.82290852 |
| 29 | Increased connective tissue (HP:0009025) | 2.76510982 |
| 30 | Peripheral hypomyelination (HP:0007182) | 2.75126094 |
| 31 | Abnormality of the corticospinal tract (HP:0002492) | 2.75072950 |
| 32 | Vertebral compression fractures (HP:0002953) | 2.71994300 |
| 33 | Cervical subluxation (HP:0003308) | 2.70076646 |
| 34 | Stridor (HP:0010307) | 2.68579454 |
| 35 | Ectopia lentis (HP:0001083) | 2.65551701 |
| 36 | Skull defect (HP:0001362) | 2.63348050 |
| 37 | Foot dorsiflexor weakness (HP:0009027) | 2.63042773 |
| 38 | Blue sclerae (HP:0000592) | 2.61378738 |
| 39 | Hematochezia (HP:0002573) | 2.60368856 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 2.59370763 |
| 41 | Cerebral hemorrhage (HP:0001342) | 2.55759320 |
| 42 | Spinal rigidity (HP:0003306) | 2.55609315 |
| 43 | Aortic aneurysm (HP:0004942) | 2.53862093 |
| 44 | Abnormality of the foot musculature (HP:0001436) | 2.52804574 |
| 45 | Hammertoe (HP:0001765) | 2.51820300 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.49585647 |
| 47 | Short hallux (HP:0010109) | 2.48165580 |
| 48 | Type 1 muscle fiber predominance (HP:0003803) | 2.46323993 |
| 49 | Buphthalmos (HP:0000557) | 2.42134381 |
| 50 | Alacrima (HP:0000522) | 2.39248980 |
| 51 | Difficulty climbing stairs (HP:0003551) | 2.38561713 |
| 52 | Parakeratosis (HP:0001036) | 2.37193180 |
| 53 | Ulnar bowing (HP:0003031) | 2.35546877 |
| 54 | Steppage gait (HP:0003376) | 2.34913736 |
| 55 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.33420565 |
| 56 | Dilatation of the ascending aorta (HP:0005111) | 2.30866610 |
| 57 | Bladder diverticulum (HP:0000015) | 2.29249004 |
| 58 | Premature skin wrinkling (HP:0100678) | 2.28899870 |
| 59 | Infantile muscular hypotonia (HP:0008947) | 2.28622968 |
| 60 | Round ear (HP:0100830) | 2.27164283 |
| 61 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.26491876 |
| 62 | Coxa vara (HP:0002812) | 2.25351628 |
| 63 | Neonatal death (HP:0003811) | 2.24735912 |
| 64 | Trismus (HP:0000211) | 2.23335177 |
| 65 | Tetraparesis (HP:0002273) | 2.22499876 |
| 66 | Pulmonary artery stenosis (HP:0004415) | 2.22098528 |
| 67 | Coronal craniosynostosis (HP:0004440) | 2.19269702 |
| 68 | Short nail (HP:0001799) | 2.18630851 |
| 69 | Sudden death (HP:0001699) | 2.18597910 |
| 70 | Action tremor (HP:0002345) | 2.15280347 |
| 71 | Wormian bones (HP:0002645) | 2.15198133 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 2.14811506 |
| 73 | Fragile skin (HP:0001030) | 2.14215658 |
| 74 | Broad face (HP:0000283) | 2.14145482 |
| 75 | Aortic valve stenosis (HP:0001650) | 2.13873623 |
| 76 | Stroke (HP:0001297) | 2.09230713 |
| 77 | Soft skin (HP:0000977) | 2.07730513 |
| 78 | Pheochromocytoma (HP:0002666) | 2.06973695 |
| 79 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.05544252 |
| 80 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.05091876 |
| 81 | Hypertriglyceridemia (HP:0002155) | 2.04048800 |
| 82 | Back pain (HP:0003418) | 2.02177788 |
| 83 | Vertebral clefting (HP:0008428) | 2.00637191 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 2.00035253 |
| 85 | Gowers sign (HP:0003391) | 1.98287547 |
| 86 | Hemorrhage of the eye (HP:0011885) | 1.97968122 |
| 87 | Bronchomalacia (HP:0002780) | 1.97648223 |
| 88 | Myotonia (HP:0002486) | 1.97071557 |
| 89 | Joint laxity (HP:0001388) | 1.95997255 |
| 90 | Myocardial infarction (HP:0001658) | 1.94186037 |
| 91 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94128846 |
| 92 | Lipoatrophy (HP:0100578) | 1.93855976 |
| 93 | Limited hip movement (HP:0008800) | 1.93456877 |
| 94 | Adactyly (HP:0009776) | 1.91264660 |
| 95 | Distal upper limb amyotrophy (HP:0007149) | 1.90632142 |
| 96 | Upper limb amyotrophy (HP:0009129) | 1.90632142 |
| 97 | Conjunctival telangiectasia (HP:0000524) | 1.90446666 |
| 98 | Hemangiomatosis (HP:0007461) | 1.90123324 |
| 99 | Hip contracture (HP:0003273) | 1.88697851 |
| 100 | Abnormality of the acetabulum (HP:0003170) | 1.88459923 |
| 101 | Aneurysm (HP:0002617) | 1.87908984 |
| 102 | Decreased motor nerve conduction velocity (HP:0003431) | 1.87766184 |
| 103 | Joint contractures involving the joints of the feet (HP:0100492) | 1.86650393 |
| 104 | Flexion contracture of toe (HP:0005830) | 1.86650393 |
| 105 | Venous abnormality (HP:0002624) | 1.86580838 |
| 106 | Intention tremor (HP:0002080) | 1.86344087 |
| 107 | Mitral valve prolapse (HP:0001634) | 1.86271067 |
| 108 | Autoamputation (HP:0001218) | 1.86212818 |
| 109 | Abnormality of dentin (HP:0010299) | 1.85033654 |
| 110 | Portal hypertension (HP:0001409) | 1.84929946 |
| 111 | Hydroureter (HP:0000072) | 1.84503060 |
| 112 | Hypopigmentation of the fundus (HP:0007894) | 1.83153649 |
| 113 | Vertebral arch anomaly (HP:0008438) | 1.82796591 |
| 114 | Aplasia involving bones of the extremities (HP:0009825) | 1.82285839 |
| 115 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.82285839 |
| 116 | Aplasia of the phalanges of the hand (HP:0009802) | 1.82285839 |
| 117 | Venous insufficiency (HP:0005293) | 1.81649357 |
| 118 | Right ventricular cardiomyopathy (HP:0011663) | 1.81000603 |
| 119 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.80661541 |
| 120 | Abnormal auditory evoked potentials (HP:0006958) | 1.80421642 |
| 121 | Neck muscle weakness (HP:0000467) | 1.79957658 |
| 122 | Oligomenorrhea (HP:0000876) | 1.79530256 |
| 123 | EMG: myopathic abnormalities (HP:0003458) | 1.79314910 |
| 124 | Supranuclear gaze palsy (HP:0000605) | 1.79125254 |
| 125 | Osteolytic defects of the hand bones (HP:0009699) | 1.77899433 |
| 126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.77899433 |
| 127 | Turricephaly (HP:0000262) | 1.77773106 |
| 128 | Mitral regurgitation (HP:0001653) | 1.77720479 |
| 129 | Abnormality of the anterior chamber (HP:0000593) | 1.77664933 |
| 130 | Overgrowth (HP:0001548) | 1.77644247 |
| 131 | Wide anterior fontanel (HP:0000260) | 1.77184024 |
| 132 | Ventricular tachycardia (HP:0004756) | 1.76525930 |
| 133 | Hypoplastic ischia (HP:0003175) | 1.76327917 |
| 134 | Hyperextensible skin (HP:0000974) | 1.76157952 |
| 135 | Camptodactyly of toe (HP:0001836) | 1.75939749 |
| 136 | Follicular hyperkeratosis (HP:0007502) | 1.75473103 |
| 137 | Mitral stenosis (HP:0001718) | 1.75025615 |
| 138 | Genu recurvatum (HP:0002816) | 1.74977324 |
| 139 | White forelock (HP:0002211) | 1.74634003 |
| 140 | Visceral angiomatosis (HP:0100761) | 1.74216131 |
| 141 | Vascular tortuosity (HP:0004948) | 1.73451787 |
| 142 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.73291028 |
| 143 | Bell-shaped thorax (HP:0001591) | 1.71946912 |
| 144 | Absent hand (HP:0004050) | 1.71270122 |
| 145 | Lower limb muscle weakness (HP:0007340) | 1.70845000 |
| 146 | Joint stiffness (HP:0001387) | 1.70699071 |
| 147 | Abnormality of the hepatic vasculature (HP:0006707) | 1.70415577 |
| 148 | Abnormal vertebral ossification (HP:0100569) | 1.69690781 |
| 149 | Ankyloglossia (HP:0010296) | 1.69503206 |
| 150 | Atrial fibrillation (HP:0005110) | 1.68718125 |
| 151 | Esophageal atresia (HP:0002032) | 1.68717564 |
| 152 | Disproportionate tall stature (HP:0001519) | 1.68145137 |
| 153 | Lymphangioma (HP:0100764) | 1.67091951 |
| 154 | Arterial tortuosity (HP:0005116) | 1.66215762 |
| 155 | Peritonitis (HP:0002586) | 1.66110586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.00175123 |
| 2 | TIE1 | 4.08599756 |
| 3 | EPHB1 | 2.96909904 |
| 4 | MET | 2.96844722 |
| 5 | OXSR1 | 2.87925029 |
| 6 | FGFR2 | 2.51626767 |
| 7 | TTN | 2.37973030 |
| 8 | ICK | 2.33612767 |
| 9 | WNK4 | 2.27529617 |
| 10 | LIMK1 | 2.23715243 |
| 11 | BCR | 2.17883299 |
| 12 | MYLK | 2.10889533 |
| 13 | WNK1 | 2.08607241 |
| 14 | NTRK1 | 2.07285492 |
| 15 | KDR | 1.85799476 |
| 16 | EPHB2 | 1.84820429 |
| 17 | CAMK1D | 1.68882486 |
| 18 | DMPK | 1.68813707 |
| 19 | CAMK1G | 1.68577958 |
| 20 | PDGFRA | 1.59948450 |
| 21 | PTK2B | 1.53594666 |
| 22 | LMTK2 | 1.43552230 |
| 23 | DDR2 | 1.42368324 |
| 24 | TRIB3 | 1.42302706 |
| 25 | TGFBR1 | 1.41941990 |
| 26 | EEF2K | 1.40325354 |
| 27 | PAK3 | 1.31875500 |
| 28 | TRPM7 | 1.31764153 |
| 29 | CSNK1A1L | 1.30849499 |
| 30 | ROCK2 | 1.29987375 |
| 31 | FES | 1.29671254 |
| 32 | PRPF4B | 1.27808860 |
| 33 | CSNK1G3 | 1.23016712 |
| 34 | TESK1 | 1.21711212 |
| 35 | PKN1 | 1.21343970 |
| 36 | TYRO3 | 1.21237122 |
| 37 | MAPKAPK3 | 1.20351110 |
| 38 | PAK2 | 1.16854905 |
| 39 | LATS1 | 1.16315673 |
| 40 | TGFBR2 | 1.16279620 |
| 41 | PHKG2 | 1.12841048 |
| 42 | PHKG1 | 1.12841048 |
| 43 | RIPK1 | 1.11634999 |
| 44 | CSNK1G1 | 1.10846962 |
| 45 | FER | 1.10515295 |
| 46 | PDGFRB | 1.10083596 |
| 47 | ERN1 | 1.09477141 |
| 48 | PAK6 | 1.09341990 |
| 49 | PTK2 | 1.05904174 |
| 50 | MAP3K3 | 1.01967140 |
| 51 | PRKD1 | 1.01567519 |
| 52 | MOS | 1.01022803 |
| 53 | ARAF | 0.96117693 |
| 54 | FGR | 0.94855973 |
| 55 | CDK19 | 0.93730718 |
| 56 | UHMK1 | 0.92300809 |
| 57 | CSNK1G2 | 0.85674568 |
| 58 | FGFR4 | 0.84863331 |
| 59 | KSR2 | 0.84439758 |
| 60 | MAP3K6 | 0.84341299 |
| 61 | ROCK1 | 0.81375067 |
| 62 | RET | 0.80852723 |
| 63 | RPS6KA2 | 0.80850682 |
| 64 | BMX | 0.79185327 |
| 65 | CAMK2D | 0.78886597 |
| 66 | PNCK | 0.77475677 |
| 67 | MAPK12 | 0.77270165 |
| 68 | MARK2 | 0.76459697 |
| 69 | GSK3A | 0.76395329 |
| 70 | PIK3CA | 0.76390469 |
| 71 | SIK1 | 0.76357555 |
| 72 | ABL2 | 0.76353710 |
| 73 | CAMK2B | 0.71866188 |
| 74 | NEK6 | 0.71713212 |
| 75 | PDPK1 | 0.70673789 |
| 76 | ILK | 0.70364841 |
| 77 | PRKD3 | 0.68393281 |
| 78 | EPHA2 | 0.67195365 |
| 79 | FLT3 | 0.66260895 |
| 80 | PRKCH | 0.66162297 |
| 81 | MST1R | 0.65927044 |
| 82 | MAPKAPK5 | 0.62812502 |
| 83 | PKN2 | 0.62166978 |
| 84 | NEK9 | 0.60111446 |
| 85 | LRRK2 | 0.60061943 |
| 86 | MAP2K1 | 0.59071977 |
| 87 | CAMK2G | 0.58702212 |
| 88 | MAPK7 | 0.58059546 |
| 89 | INSR | 0.57888855 |
| 90 | MTOR | 0.57314364 |
| 91 | CLK1 | 0.55858777 |
| 92 | CDK14 | 0.55598119 |
| 93 | CSK | 0.55204547 |
| 94 | FGFR1 | 0.52519972 |
| 95 | PRKAA2 | 0.52077052 |
| 96 | MAP2K2 | 0.51624006 |
| 97 | PDK2 | 0.51560731 |
| 98 | PBK | 0.51264848 |
| 99 | MAPK15 | 0.50805302 |
| 100 | PTK6 | 0.49940358 |
| 101 | SMG1 | 0.48824680 |
| 102 | CDC42BPA | 0.48051584 |
| 103 | FYN | 0.46413877 |
| 104 | PRKCE | 0.46213404 |
| 105 | GRK5 | 0.45030182 |
| 106 | MAP3K2 | 0.44998614 |
| 107 | STK38 | 0.44760101 |
| 108 | MAP3K13 | 0.44257174 |
| 109 | IRAK3 | 0.44007275 |
| 110 | SRC | 0.43125697 |
| 111 | CDK5 | 0.41970191 |
| 112 | PAK4 | 0.41629664 |
| 113 | MAPK4 | 0.41620132 |
| 114 | PAK1 | 0.41541205 |
| 115 | MAP2K3 | 0.41047386 |
| 116 | DAPK3 | 0.40972374 |
| 117 | PRKG2 | 0.40246841 |
| 118 | OBSCN | 0.40179154 |
| 119 | INSRR | 0.38489628 |
| 120 | CAMK1 | 0.38138876 |
| 121 | EPHA3 | 0.37779398 |
| 122 | ERBB4 | 0.37451726 |
| 123 | STK11 | 0.37227035 |
| 124 | ZAP70 | 0.36240985 |
| 125 | KIT | 0.36238531 |
| 126 | LATS2 | 0.35479650 |
| 127 | AKT2 | 0.34648653 |
| 128 | PRKACB | 0.34172450 |
| 129 | PRKAA1 | 0.33792339 |
| 130 | CDK15 | 0.33382804 |
| 131 | STK10 | 0.31892153 |
| 132 | PIM2 | 0.31605551 |
| 133 | PRKD2 | 0.31348200 |
| 134 | MAP3K1 | 0.31325545 |
| 135 | NTRK3 | 0.30959448 |
| 136 | MAP3K7 | 0.30739714 |
| 137 | IGF1R | 0.28650334 |
| 138 | ADRBK1 | 0.28083501 |
| 139 | CDK9 | 0.26594104 |
| 140 | CDK6 | 0.21121320 |
| 141 | PIK3CG | 0.20824095 |
| 142 | MARK1 | 0.20484376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.34600310 |
| 2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.15792951 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.70642179 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.50871927 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.40760047 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.33329586 |
| 7 | Axon guidance_Homo sapiens_hsa04360 | 2.11504314 |
| 8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.07323356 |
| 9 | Tight junction_Homo sapiens_hsa04530 | 2.02677925 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.90861391 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.90142377 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.74626601 |
| 13 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.74467313 |
| 14 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.72879608 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.69154899 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.67483346 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.65086344 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61560791 |
| 19 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.60446784 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56090334 |
| 21 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.49940572 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.45749948 |
| 23 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.40921782 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.37733503 |
| 25 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.36392362 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.34136316 |
| 27 | Amoebiasis_Homo sapiens_hsa05146 | 1.32401253 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31324404 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.28450647 |
| 30 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.27648511 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25461489 |
| 32 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.25373378 |
| 33 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22511372 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21479591 |
| 35 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.20567635 |
| 36 | Adherens junction_Homo sapiens_hsa04520 | 1.15949002 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12382289 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12045780 |
| 39 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.08821401 |
| 40 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.08319302 |
| 41 | Endocytosis_Homo sapiens_hsa04144 | 1.08189872 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07564031 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.06834064 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06199103 |
| 45 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.02135017 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99583125 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 0.97996930 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97056500 |
| 49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96996738 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93904166 |
| 51 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.93656768 |
| 52 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.93064292 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91284341 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91251273 |
| 55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.90670395 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90669725 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.89385991 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87166991 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86407993 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86032832 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85253201 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.85247258 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84240502 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83385725 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82710423 |
| 66 | Gap junction_Homo sapiens_hsa04540 | 0.82365541 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81106445 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.79601609 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78969820 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.76609476 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76512664 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76240375 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75972495 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75359156 |
| 75 | Pathways in cancer_Homo sapiens_hsa05200 | 0.74890019 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74654182 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72593768 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72436116 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71728671 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70718725 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70168104 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70113905 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69902757 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69455452 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68995037 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68746968 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67463210 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65871490 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65631960 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64710466 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64557559 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63160869 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63133113 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63123534 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62725508 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62351679 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.61950100 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60663970 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.60455266 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58911477 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58769347 |
| 102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58329456 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.58173654 |
| 104 | Long-term depression_Homo sapiens_hsa04730 | 0.57898091 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57630710 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.56825003 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56740961 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55692920 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54335407 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53439902 |
| 111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52920274 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52513484 |
| 113 | Salivary secretion_Homo sapiens_hsa04970 | 0.51915118 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51514550 |
| 115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49917457 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.49616815 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48385839 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.47227617 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46230522 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45642337 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45368937 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45135269 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44878528 |
| 124 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44718760 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43516097 |
| 126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43465960 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43434101 |
| 128 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42794847 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42728756 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42567961 |
| 131 | Melanoma_Homo sapiens_hsa05218 | 0.42421232 |
| 132 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42384300 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.39932959 |
| 134 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39219140 |

